3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Radiation Injuries
4
Medulloblastoma
3
Choroid Plexus Neoplasms
3
Central Nervous System Neoplasms
3
Brain Neoplasms
3
Astrocytoma
3
Pinealoma
2
Oligodendroglioma
2
Neuroectodermal Tumors, Primitive
2
Meningioma
2
Gliosarcoma
2
Glioma, Subependymal
2
Glioma
2
Glioblastoma
2
Fatigue
2
Ependymoma
2
Depression
2
Craniopharyngioma
2
Cognitive Dysfunction
2
Breast Neoplasms
2
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Sleep Wake Disorders
1
Pain
1
Optic Nerve Glioma
1
Neurotoxicity Syndromes
1
Neoplasms
1
Neoplasm Metastasis
1
Memory Disorders
1
Lung Neoplasms
1
Interventions
Fentanyl
3
Sodium Chloride
2
Pregabalin
2
Morphine
2
Mindfulness-Based Stress Reduction
2
Ketamine
2
Hypnosis
2
Dexmedetomidine
2
Bupivacaine
2
Anesthetics, Local
2
tianeptine
1
Waiting Lists
1
Transcutaneous Electric Nerve Stimulation
1
Therapeutics
1
Telemedicine
1
Tea
1
Surveys and Questionnaires
1
Spinal Cord Stimulation
1
Ropivacaine
1
Plastic Surgery Procedures
1
Nerve Block
1
Mindfulness-Based Cognitive Therapy
1
Mindfulness
1
Methadone
1
Meloxicam
1
Lidocaine
1
Ketorolac Tromethamine
1
Ketorolac
1
Exercise Therapy
1
Epinephrine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Chronic Pain
×
Donepezil
×
Clear all
NCT05254639
2024-04-05
DONEPEZOX
University Hospital, Clermont-Ferrand
Phase 2
Completed
77 enrolled